Healthcare & elderly care
Joint venture, cooperation and sole proprietorship
The advanced production technology adopted in this project has independent intellectual property rights and national patents. With the domestic leading level, the market share of this product accounts for more than 70% of the similar domestic products. It will have a great impact on the development of hormone drugs industry in China.
The hormone crude drug intermediates project with an annual output of 1,000 tons is located in Dingtao District of Heze City. The project covers an area of 200,000 square meters and focuses on building a high-tech park mainly for bio-pharmaceutical products, including 21- hydroxypregnene-1,4,9(11),16- tetraene -3,20- diketone -21- acetate (3-TR), medroxyprogesterone (8-DM) and 4- pregnene -17a,21- diol -3,20- diketone -21- acetate (hydrocortisone intermediates).
After being put into operation, the annual output of hormone crude drug intermediates will be 1,000 tons, with sales revenue of RMB 4 billion and profit and tax of RMB 2 billion.
Wang Xingwen and Liu Fuhai 0530-6226266